Translational Medicine: Open Access(TMOA)
ISSN: 2993-5407 | DOI: 10.33140/TMOA
Aims and Scope
Journal DOI: 10.33140/TMOA
Translational Medicine: Open Access publishes the most current research related to medical and clinical research in the field of Translational Medicine with most comprehensive and reliable information in all the disciplines of clinical and translational research in Medicine, treatments and diagnosis. The quality of the Editorial Board follows the Peer review process. The time to publish the articles from date of submission is maximum 30-35 days.
We welcome articles from Professors, microbiologists, biotechnologists, clinicians, scientists, research scholars and medical practitioners. We will publish all types of articles like clinical cases, case reports, research articles, review, short communication, commentarty, image articles, PPTs, letter to the Editor and Editorials.
Submit manuscript at https://www.opastpublishers.com/journal/archives-of-clinical-and-medical-microbiology/manuscript-submission or send as an e-mail attachment to the Editorial Office at info@opastpublishers.com
Translational Medicine: Open Access 2993-5407 is an online open-access journal that provides an advanced forum related to medical and clinical research in the field of Translational Medicine.
Following are some of the fields that the journal covers:
|
Interdisciplinarity |
T cell |
Pharmacopoeia |
|
Transdisciplinarity |
B cell |
Endotoxicology |
|
Collaboration |
RNA virus |
Pharmacotherapy |
|
Translation |
DNA virus |
Environmental pharmacology |
|
Organ Translation |
Drug target |
Pharmakos |
|
Skin Translation |
Translational Hematology |
Environmental toxicology |
|
Pharmacokinetics |
Translational medicine |
Posology |
|
Pediatric Transplantation |
Clinical Trials |
Enzyme inhibition |
|
Translational Therapeutics |
Biomarkers |
Psychopharmacology |
|
Functional genomics |
Drug Development |
Forensic toxicology |
|
Molecular Diagnostics |
Precision Medicine |
Systems pharmacology |
|
Genetic association studies |
Personalized Medicine |
Molecular epidemiology |
|
Genetics and Genomics |
Genomics |
Assembly |
|
Pharmacogenomics |
Proteomics |
Acute infection |
|
epigenetics in relation to cancer biology |
Bioinformatics |
Smart Sensors |
|
Cellular and Molecular Biology |
Data Mining |
Health Monitoring |
|
Diagnosis and therapy |
Artificial Intelligence |
Predictive Modeling |
|
Epidemiology |
Machine Learning |
Data Analytics |
|
Tumor immunology |
Targeted Therapy |
Decision Analysis |
|
Breast Cancer |
Therapeutic Antibodies |
Health Systems Research |
|
Cancer and tumor immunology |
Pharmacodynamics |
Health Services Research |
|
Lung Cancer |
Drug Safety |
Implementation Science |
|
Tumor immunity |
Drug Efficacy |
Health Education |
|
Gastrointestinal Cancer |
Drug Toxicity |
Health Literacy |
|
Immunotherapy |
Preclinical Studies |
Health Communication |
|
Skin Cancer |
Animal Models |
Clinical Decision Support Systems (Cdss) |
|
Cancer vaccines |
Drug Discovery |
Patient-Centered Care |
|
Translational And Clinical Research In Cancer |
High-Throughput Screening |
Patient Engagement |
|
Critical Care |
Stem Cells |
Health Disparities |
|
Surgery |
Regenerative Medicine |
Health Outcomes |
|
Surgical pathology |
Tissue Engineering |
Health Economics |
|
Cell and molecular biology |
Drug Delivery |
Health Technology Assessment |
|
Gene editing |
Nanotechnology |
Health Policy |
|
Isease modeling |
Microfluidics |
Health Informatics |
|
metabolism |
Point-Of-Care Testing |
Clinical Informatics |
|
Satellite cells |
Companion Diagnostics |
Public Health Informatics |
|
Muscle stem cells |
Imaging Techniques |
Regulatory Science |
|
Antigen presentation |
Magnetic Resonance Imaging (Mri) |
Drug Approval Process |
|
Immunosurveillance |
Computed Tomography (Ct) |
Clinical Trial Design |
|
Progenitor cells |
Positron Emission Tomography (Pet) |
Clinical Trial Management |
|
Amyotrophic lateral sclerosis |
Single-Photon Emission Computed Tomography (Spect) |
Pharmacovigilance |
|
Neuropathic pain |
Ultrasound |
Adverse Drug Reactions |
|
Neurodegenerative diseases |
Molecular Imaging |
Drug Interactions |
|
Clinical and translational research |
Optical Imaging |
Drug Repurposing |
|
Tissue-specific Stem Cells |
Radiomics |
Drug Repositioning |
|
Stem Cell Genomes |
Transcriptomics |
Biomaterials |
|
Hematopoiesis |
Epigenomics |
Artificial Organs |
|
Gene Therapy |
Metabolomics |
Biosensors |
|
Cell Targeting Cell |
Lipidomics |
Wearable Technology |
|
Neuropsychopharmacology |
Glycomics |
Health Promotion |
|
Cardiovascular pharmacollogy |
Metagenomics |
Clinical Metagenomics |
|
Occupational toxicology |
Microbiome |
Digital Health |
|
Clinical pharmacology |
Clinical Genomics |
Telemedicine |
|
Pharmaceutical formulation |
Clinical Proteomics |
Electronic Health Records (Ehrs) |
|
Cosmeceuticals |
Clinical Metabolomics |
Health Information Exchange (Hie) |
|
Pharmacoepidemiology |
Clinical Lipidomics |
Dental pharmacology |
|
Crude drugs |
Clinical Glycomics |
Drug metabolism |
|
Pharmacogenetics |
Ecotoxicology |
Health |
|
Pharmacognosy |